🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Recurrent Non-Muscle Invasive Bladder Carcinoma

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer NCT06173349Phase 11 site📍 Sacramento University of California, Davis · Tests: PLZ4-coated paclitaxel loaded micelles (PPM) Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy NCT07000084Phase 360 sites📍 Birmingham📍 Fairbanks📍 Gilbert Alliance for Clinical Trials in Oncology · Tests: BCG Solution, Biopsy of Bladder, Cystoscopy, Computed Tomography, Magnetic Resonance Imaging A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) NCT06637423Phase 1, Phase 213 sites📍 Bakersfield📍 Tampa📍 Chicago Merck Sharp & Dohme LLC · Tests: Sacituzumab tirumotecan, Rescue medication, Supportive care measures Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer NCT06781879Phase 48 sites📍 Aalborg📍 Aarhus N📍 Herlev Jakob Kristian Jakobsen · Tests: Mitomycin c A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer NCT05521698Phase 16 sites📍 Tucson📍 Los Angeles📍 Bethesda University of Wisconsin, Madison · Tests: Bicalutamide, Biopsy Procedure, Biospecimen Collection, Questionnaire Administration, Transurethral Resection of Bladde… Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer NCT07420517Phase 21 site📍 Québec Paul Toren · Tests: Dutasteride (0.5mg) A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer NCT06733363Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Behavioral Dietary Intervention, Telephone- Based Intervention Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC NCT07322263Phase 21 site📍 Iowa City Michael A. O'Donnell · Tests: Intravesical Gemcitabine and Docetaxel Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment NCT06766266Phase 11 site📍 Chongqing First Affiliated Hospital of Chongqing Medical University · Tests: Irinotecan liposome II combination therapy regimen, Irinotecan liposome II combination therapy regimen Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) NCT05037279Phase 36 sites📍 Vancouver📍 Kingston📍 Toronto Verity Pharmaceuticals Inc. · Tests: Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus Calmette-Guerin: Strain TICE AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer NCT05002556n/a44 sites📍 Aix-en-Provence📍 Angers📍 Arras Association Francaise d'Urologie Effects of Microbiological and Immunological Factors on the Lower Urinary Tract NCT07494864n/a1 site📍 Zurich University of Zurich Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer NCT06441110Phase 31 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Tislelizumab in Combination with Bacillus Calmette-Guérin A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer NCT05710848Phase 1, Phase 220 sites📍 Mesa📍 Tucson📍 Little Rock SURGE Therapeutics · Tests: STM-416 Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 NCT07225127n/a6 sites📍 Tampa📍 Iowa City📍 Chapel Hill University of Washington A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC NCT07725796Phase 115 sites📍 Queen Creek📍 Bakersfield📍 Murrieta UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. · Tests: UGN-501 Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer NCT05982561n/a3 sites📍 Little Rock📍 Indianapolis📍 St Louis Early is Good Inc. Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. NCT06167356n/a1 site📍 Milan IRCCS San Raffaele Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer NCT05337397n/a1 site📍 Aarhus Jørgen Bjerggaard Jensen · Tests: Laser ablation Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial NCT06770582Phase 2147 sites📍 Tucson📍 Fayetteville📍 Rogers National Cancer Institute (NCI) · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Fluorouracil, Gemcitabine Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer NCT06732531Phase 1, Phase 26 sites📍 Beijing📍 Xiamen📍 Changsha Zhuhai Beihai Biotech Co., Ltd · Tests: BH011 A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD) NCT06991868n/a1 site📍 Beijing Peking University First Hospital Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients NCT05739968NA1 site📍 Taipei National Taiwan University Hospital · Tests: Usual care + oncology case manager (OCM) care, Multi-domains Active-living Program (MAP) with e-health enhanced interve… Prospective Sample Collection for Cancer of Bladder NCT03973671n/a1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy